Tag: clinical trials

Regulatory Expectations for Handling Serious Breaches of GCP

November 19, 2025November 16, 2025 digi

Regulatory Expectations for Handling Serious Breaches of GCP Understanding Regulatory Expectations for Handling Serious Breaches of GCP Introduction The conduct of clinical trials is governed by stringent guidelines to ensure that the safety, efficacy, and integrity of data are consistently upheld. Among these guidelines, Good Clinical Practice (GCP) serves as a framework outlining responsibilities and…

Definitions: Deviation vs. Violation

Digital Tools and Automation to Streamline Trial Registration (ClinicalTrials.gov, EU CTR)

November 19, 2025November 16, 2025 digi

Digital Tools and Automation to Streamline Trial Registration (ClinicalTrials.gov, EU CTR) Digital Tools and Automation to Streamline Trial Registration The process of registering clinical trials is a critical component in maintaining transparency and upholding the integrity of the clinical research process. It is essential for all professionals involved in clinical operations, regulatory affairs, and medical…

Trial Registration (ClinicalTrials.gov, EU CTR)

Inspection and Audit Readiness: Documenting Trial Registration (ClinicalTrials.gov, EU CTR) for Regulators

November 19, 2025November 16, 2025 digi

Inspection and Audit Readiness: Documenting Trial Registration (ClinicalTrials.gov, EU CTR) for Regulators In the complex landscape of clinical trials, maintaining compliance with regulatory requirements is critical for ensuring the integrity of the research and the safety of participants. Documenting trial registration in systems like ClinicalTrials.gov and the EU Clinical Trials Register (EU CTR) is a…

Trial Registration (ClinicalTrials.gov, EU CTR)

Common Deficiencies in Investigator’s Brochure (IB) Authoring & Updates Highlighted in FDA, EMA and MHRA Inspections

November 19, 2025November 16, 2025 digi

Common Deficiencies in Investigator’s Brochure (IB) Authoring & Updates Highlighted in FDA, EMA and MHRA Inspections The Investigator’s Brochure (IB) is a critical document in the clinical trial process, providing essential information about the investigational drug or device for those involved in the trial. Common deficiencies found in IB authoring and updates can lead to…

Investigator’s Brochure (IB) Authoring & Updates

Real-World Examples of Deviations vs Violations in Oncology and Rare Disease Trials

November 19, 2025November 16, 2025 digi

Real-World Examples of Deviations vs Violations in Oncology and Rare Disease Trials Real-World Examples of Deviations vs Violations in Oncology and Rare Disease Trials Introduction to Clinical Trial Protocol Deviations and Violations Clinical trials are meticulously designed studies aimed at evaluating the efficacy and safety of new treatments, especially in complex areas like oncology and…

Definitions: Deviation vs. Violation

Building Job Aids to Help Sites Classify Deviations Consistently

November 19, 2025November 16, 2025 digi

Building Job Aids to Help Sites Classify Deviations Consistently Building Job Aids to Help Sites Classify Deviations Consistently Introduction to Protocol Deviations and Violations In the context of clinical trials, accurately classifying protocol deviations and violations is crucial for ensuring compliance with regulatory standards and safeguarding patient safety. Deviations refer to departures from the protocol…

Definitions: Deviation vs. Violation

Aligning Trial Registration (ClinicalTrials.gov, EU CTR) With ICH, GCP and Transparency Regulations

November 19, 2025November 16, 2025 digi

Aligning Trial Registration (ClinicalTrials.gov, EU CTR) With ICH, GCP and Transparency Regulations In the landscape of clinical research, maintaining compliance with regulatory frameworks is paramount for clinical operations, regulatory affairs, and medical affairs professionals. This article serves as a detailed guide aimed at elucidating the steps required for aligning trial registration processes with international standards…

Trial Registration (ClinicalTrials.gov, EU CTR)

Trial Registration (ClinicalTrials.gov, EU CTR) Playbook for High-Profile and Late-Phase Trials

November 19, 2025November 16, 2025 digi

Trial Registration (ClinicalTrials.gov, EU CTR) Playbook for High-Profile and Late-Phase Trials Trial Registration (ClinicalTrials.gov, EU CTR) Playbook for High-Profile and Late-Phase Trials The process of trial registration is a critical component of clinical research, ensuring transparency and access to information for all stakeholders involved. This guide serves as a comprehensive playbook for high-profile and late-phase…

Trial Registration (ClinicalTrials.gov, EU CTR)

Investigator’s Brochure (IB) Authoring & Updates in Practice: Step-by-Step Guide for Sponsors, CROs and Sites

November 19, 2025November 16, 2025 digi

Investigator’s Brochure (IB) Authoring & Updates in Practice: Step-by-Step Guide for Sponsors, CROs and Sites Investigator’s Brochure (IB) Authoring & Updates in Practice: Step-by-Step Guide for Sponsors, CROs and Sites The Investigator’s Brochure (IB) is a critical document in the realm of clinical trial research. It functions as a comprehensive resource for investigators, providing essential…

Investigator’s Brochure (IB) Authoring & Updates

Deviation, Major Deviation and Serious Breach: Where to Draw the Line

November 19, 2025November 16, 2025 digi

Deviation, Major Deviation and Serious Breach: Where to Draw the Line Deviation, Major Deviation and Serious Breach: Where to Draw the Line Clinical trials are pivotal for advancing medical knowledge and treatment options. However, the successful conduct of these trials necessitates strict adherence to protocols and regulatory requirements. Understanding the terminology related to non-compliance, specifically…

Definitions: Deviation vs. Violation